Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone

NCT00493766 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Because of a strategic decision by Novartis

Conditions

Hormone Refractory Prostate Cancer

Interventions

DRUG: LBH589

Sponsor

Novartis Pharmaceuticals